MERMAID BIO
Dead / Cancelled — Cancelled — Section 8 (as of 13 Feb 2026)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88225561
- Registration number
- 5819333
- Mark type
- Stylized text
- Filed
- 11 Dec 2018
- Published for opposition
- 14 May 2019
- Registered
- 30 Jul 2019
- Attorney of record
- David S. Kerr
Goods and services
- Class 042 — Scientific and technological services: Medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit pathogens directed to aquatic organism; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit pathogens directed to aquatic organism grown in aquaculture; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms; Research and development of biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms grown in aquaculture; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms; Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit the expression of target genes in pathogens affecting to aquatic organisms grown in aquaculture; Research and development biopharmaceutical compounds, namely, RNA-based therapeutic agents to inhibit bacterial quorum-sensing Research and development of genetically engineered organisms, namely, genetically engineered bacteria that produce RNA-based therapeutic agents to inhibit bacterial quorum-sensing; Research and development of new biological products for therapeutic use to prevent or treat aquatic diseases; Research and development of new biological products for therapeutic use to prevent or treat diseases affecting animals grown in aquaculture
Owner
- PEBBLE LABS, INC., LOS ALAMOS, NM, US
- PEBBLE LABS INC., SANTA FE, NM, US
- Pebble Labs Inc., Los Alamos, NM, CA
- Pebble Labs Inc., Los Alamos, NM, CA
- Pebble Labs Inc., Los Alamos, NM, CA
Prosecution history
- 13 Feb 2026 — CANCELLED SEC. 8 (6-YR)
- 30 Jul 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 06 Jan 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Oct 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 30 Jul 2019 — REGISTERED-PRINCIPAL REGISTER
- 14 May 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 May 2019 — PUBLISHED FOR OPPOSITION
- 24 Apr 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Apr 2019 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 05 Apr 2019 — ASSIGNED TO LIE
- 14 Mar 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Mar 2019 — EXAMINER'S AMENDMENT ENTERED
- 14 Mar 2019 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 Mar 2019 — EXAMINERS AMENDMENT E-MAILED
- 14 Mar 2019 — EXAMINERS AMENDMENT -WRITTEN